BibTex format
@article{Pfaar:2018:10.5414/ALX02053,
author = {Pfaar, O and Bastl, K and Berger, U and Buters, J and Calderon, MA and Clot, B and Darsow, U and Demoly, P and Durham, SR and Gala'n, C and Gehrig, R and van, Wijk RG and Jacobsen, L and Klimek, L and Sofiev, M and Thibaudon, M and Bergmann, KC},
doi = {10.5414/ALX02053},
journal = {ALLERGOLOGIE},
pages = {386--399},
title = {Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper},
url = {http://dx.doi.org/10.5414/ALX02053},
volume = {41},
year = {2018}
}
RIS format (EndNote, RefMan)
TY - JOUR
AU - Pfaar,O
AU - Bastl,K
AU - Berger,U
AU - Buters,J
AU - Calderon,MA
AU - Clot,B
AU - Darsow,U
AU - Demoly,P
AU - Durham,SR
AU - Gala'n,C
AU - Gehrig,R
AU - van,Wijk RG
AU - Jacobsen,L
AU - Klimek,L
AU - Sofiev,M
AU - Thibaudon,M
AU - Bergmann,KC
DO - 10.5414/ALX02053
EP - 399
PY - 2018///
SN - 0344-5062
SP - 386
TI - Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper
T2 - ALLERGOLOGIE
UR - http://dx.doi.org/10.5414/ALX02053
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446028900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
VL - 41
ER -